Cleary Gottlieb represented Indian pharmaceutical firm Wockhardt Limited in its acquisition of Negma Laboratories, a deal that will make Wockhardt Europe’s largest Indian pharma company. The $265 million all-cash transaction signed on May 2 and closed on May 16.
Negma is Wockhardt’s largest acquisition to date and its fifth in Europe.
Wockhardt is a global pharmaceutical and biotechnology company with a portfolio of 130 products in Europe. Negma is the fourth largest independent pharmaceutical group in France with 172 patents.